Learn more

QIAGEN GENOMICS INC

Overview
  • Total Patents
    46
About

QIAGEN GENOMICS INC has a total of 46 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, biotechnology and chemical engineering are RAPIGENE INC, NIMBLEGEN SYSTEMS INC and HIGH THROUGHPUT GENOMICS INC.

Patent filings per year

Chart showing QIAGEN GENOMICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tabone John C 33
#2 Van Ness Jeffrey 19
#3 Ness Jeffrey Van 18
#4 Mulligan John T 16
#5 Moynihan Kristen 12
#6 Howbert J Jeffry 8
#7 Garrison Lori K 7
#8 Howbert Jeffry 6
#9 Winter Stephen B D 5
#10 Skead Benjamin M 5

Latest patents

Publication Filing date Title
AU3269401A Simultaneous hybridization/priming for snp analysis
AU7733200A Compositions and methods for reducing oligonucleotide hybridization and priming specificity
WO0116090A1 Enantiomerically-enriched compounds having photocleavable bond(s) and methods related thereto
NZ501919A Methods for analyzing nucleic acid molecules utilizing mass spectroscopy readable tags
NZ501776A Spring probe and methods for arraying oligonucleotide and thickening agent to a solid support
NZ501968A Polyethylenimine-based biomolecule arrays
AU8503298A Amplification and other enzymatic reactions performed on nucleic acid arrays
NZ501774A Computer method and system for correlating known characteristics of biomolecules to molecular tags with unique molecular weights that are associated with the biomolecule
US6361940B1 Compositions and methods for enhancing hybridization and priming specificity
US6613508B1 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
US6312893B1 Methods and compositions for determining the sequence of nucleic acid molecules
EP0868535A2 Methods and compositions for determining the sequence of nucleic acid molecules
EP0962464A2 Methods and compositions for detecting binding of ligand pair using non-fluorescent label